iShares S&P 100 ETF Drops Nike, Colgate for AI Stocks
A major blue-chip ETF swapped consumer staples for AI infrastructure plays, signaling a quiet but significant shift in what 'safe' investing now means.
The iShares S&P 100 ETF, long regarded as a bedrock holding for conservative investors seeking exposure to America's largest and most stable companies, has made a notable rebalancing move — ejecting Nike and Colgate in favor of four artificial intelligence infrastructure stocks. The swap is more than a routine index adjustment. It reflects how dramatically the definition of a blue-chip company has shifted in just a few years.
For decades, names like Colgate-Palmolive represented exactly what cautious investors wanted: steady dividends, recession-resistant demand, and predictable earnings. Nike carried similar prestige as a globally dominant consumer brand. Their removal from a fund designed to track the 100 largest U.S. companies is a signal that market capitalization itself has been reshaped by the AI investment wave, pushing legacy consumer names down the rankings while technology and AI infrastructure companies surge upward.
Read more Apple Stock Before Its Launch Event: Buy, Wait, or Pass? →
The practical implication for everyday investors is worth pausing on. Many people hold S&P 100 or similar large-cap ETFs precisely because they believe they are insulated from the volatility of speculative tech bets. But passive index investing, by its very design, means your portfolio automatically absorbs whatever the market decides is valuable — and right now, the market has decided that AI infrastructure is the new defensive play. Whether that judgment proves durable or reflects peak enthusiasm remains an open question.
What this rebalancing quietly reveals is the tension at the heart of index investing in an era of sector disruption. A fund marketed on the stability of household names is now, without any active decision by its holders, increasingly a vehicle for concentrated AI exposure. Investors who assumed they were buying diversified blue-chip safety may want to look under the hood and reassess whether their actual risk profile still matches their intentions.
Continue reading at Yahoo.
